Institute of Clinical Cancer Research (ICCR)

The Institute of Clinical Cancer Research (ICCR) is a joint academic clinical research facility of the University Cancer Center Frankfurt and Krankenhaus Nordwest gGmbH founded to advance and develop clinical cancer research. ICCR mainly focuses on phase I and proof-of-concept trials, phase III trials and research on health-related quality of life and patients’ preferences. The institute has an own phase I unit for early phase trials and coordinates a nationwide network of more than 500 clinical facilities for the conduct of its phase III trials. ICCR supports academically initiated clinical research with its expertise and offers a wide range of solutions to both pharmaceutical and biotechnological industry for the development and market authorization of their products.

We cordially invite you to get acquainted with our institute, expertise and our ongoing clinical trials on the following pages.